Sorafenib is an Orally Active Raf Inhibitor for Kinds of Cancers Research
Sorafenib is an oral multi-kinase inhibitor that inhibits cell proliferation through a strong inhibition of the serine/threonine kinase RAF. Sorafenib was initially approved by the FDA for treatment of metastatic…